Acute HCV infection detected in a blood donor by NAT [2]

Transfusion

Volumn 43, Issue 1, 2003, Pages 116-118

  Coste, J ^e   Levayer, T ^a   Izopet, J ^b   Laperche, S ^c   Parneix, P ^d   Rech, H ^a   Payen, J L ^b   Schved, J F ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b CHU PURPAN   (France)

^c National Blood Transfusion Institute   (France)

^d HÔPITAL PELLEGRIN   (France)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS ANTIBODY;

ADULT; BLOOD DONOR; CASE REPORT; DIAGNOSTIC KIT; ENDOSCOPY; ENZYME IMMUNOASSAY; HEPATITIS C; HUMAN; LETTER; MALE; SCREENING TEST; SEQUENCE HOMOLOGY; VIRUS DETECTION; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION;

ACUTE DISEASE; ALANINE TRANSAMINASE; BLOOD DONORS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 0037224911     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00328.x     Document Type: Letter

References (4)

1. Martinot-Peignoux M, Roudot-Thoraval F, Mendel I, et al. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. J Viral Hepatitis 1999;6:435-43.
2. Izopet J, Rostaing L, Sandre K, et al. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients. J Infect Dis 2000;181: 852-8.
3. Knöll A, Helmig M, Peters O, Jilg W. Hepatitis C virus transmission in a pediatric oncology ward: analysis of an outbreak and review of literature. Lab Invest 2001;81:251-62.
4. Pillonel J, Laperche S, Saura C, Desenclos JC, Courouce AM. Trends in risk of transfusion-transmitted viral infections in France, 1992-2000. Transfusion 2002;42:980-8.